DLH (DLHC) Rating Increased to Buy at Zacks Investment Research

DLH (NASDAQ:DLHC) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Wednesday. The brokerage presently has a $7.00 price target on the business services provider’s stock. Zacks Investment Research‘s target price suggests a potential upside of 13.64% from the stock’s current price.

According to Zacks, “DLH Holdings Corp. serves clients throughout the United States as a full-service provider of healthcare, logistics, and technical support services to DoD and Federal agencies. Its healthcare delivery solutions include professional services, such as case management, health and injury assessment, critical care, medical/surgical, emergency room/trauma center, counseling, behavioral health and trauma brain injury, medical systems analysis, and medical logistics, and allied support services in the areas of MRI technology, diagnostic sonography, phlebotomy, dosimetry, physical therapy, and pharmaceuticals. The company’s logistics and technical services include program and project management, systems engineering and applicable information technology services, integrated logistics support, training, equipment and non-tactical vehicle operations and maintenance, and facilities and shipyard support services. DLH Holdings Corp., formerly known as TeamStaff, Inc., is headquartered in Atlanta, Georgia. “

A number of other research analysts also recently issued reports on DLHC. TheStreet upgraded shares of DLH from a “c” rating to a “b-” rating in a research report on Wednesday, November 1st. Canaccord Genuity restated a “buy” rating and set a $7.00 target price on shares of DLH in a research report on Friday, October 13th. One investment analyst has rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $7.17.

DLH (NASDAQ:DLHC) traded down $0.01 during midday trading on Wednesday, reaching $6.16. 8,690 shares of the company were exchanged, compared to its average volume of 7,382. The firm has a market capitalization of $73.32, a P/E ratio of 22.81 and a beta of 0.65. DLH has a 52 week low of $4.10 and a 52 week high of $6.83.

DLH (NASDAQ:DLHC) last posted its earnings results on Wednesday, December 6th. The business services provider reported $0.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.01). DLH had a net margin of 2.84% and a return on equity of 9.61%. analysts expect that DLH will post 0.35 EPS for the current year.

In related news, major shareholder Wynnefield Partners Small Cap sold 150,000 shares of the business’s stock in a transaction on Tuesday, December 12th. The shares were sold at an average price of $6.15, for a total transaction of $922,500.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 25.90% of the company’s stock.

Several institutional investors have recently modified their holdings of the business. Essex Investment Management Co. LLC raised its position in shares of DLH by 19.8% in the second quarter. Essex Investment Management Co. LLC now owns 28,844 shares of the business services provider’s stock worth $155,000 after acquiring an additional 4,758 shares during the period. Renaissance Technologies LLC raised its position in shares of DLH by 12.4% in the first quarter. Renaissance Technologies LLC now owns 120,140 shares of the business services provider’s stock worth $649,000 after acquiring an additional 13,250 shares during the period. Dimensional Fund Advisors LP acquired a new position in shares of DLH in the third quarter worth about $121,000. Finally, Commonwealth Equity Services Inc acquired a new position in shares of DLH in the third quarter worth about $2,342,000. Institutional investors and hedge funds own 54.33% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2018/01/17/dlh-dlhc-rating-increased-to-buy-at-zacks-investment-research-2.html.

About DLH

DLH Holdings Corp. provides healthcare and social services in the United States. It offers defense and veterans’ health solutions, including case management, physical and behavioral health examinations, and medical administration and logistics services. The company also provides a range of human services and solutions, which consists of educational and environmental support services for the underserved children and youth comprising health, nutritional, parental, and behavioral services; and IT system architecture design, migration plan, and ongoing maintenance services.

Get a free copy of the Zacks research report on DLH (DLHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for DLH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DLH and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply